Riskpilot← Back to searchSign inGet full accessClema Aktiebolag
ABActiveOrg 5568328131Gröstorps Bygata 22Physiotherapy activities · NACE 8695Est. 20103 employees
Revenue 2024
SEK 1,6M
+19% vs 2023
EBITDA margin
8.4%
+896% vs 2023
Equity ratio
39.9%
Financial strength
Net profit 2024
SEK 112K
+2266% vs 2023
| Revenue | SEK 1,6M | +19% |
| EBITDA | SEK 132K | +896% |
| Net profit | SEK 112K | +2266% |
| Total assets | SEK 304K | +81% |
| Equity | SEK 121K | +1256% |
| Employees | 3 | — |
Legal name
Clema Aktiebolag
Org number
5568328131
Legal form
Aktiebolag
NACE code
8695 · Physiotherapy activities
Founded
15 december 2010
Share capital
SEK 50 000
Employees
3 (FTE)
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas var för sig av ledamoten suppleanten
Company purpose
Bolaget ska bedriva sjukgymnastik, konsultverksamhet och handel med hjälpmedel och tillbehör inom sjukgymnastikområdet, kursverksamhet inom områdena barn och musik, handel med barn- och musikartiklar samt därmed förenlig verksamhet.
Address
Gröstorps Bygata 22
Email
cjaverud@hotmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 1 381 | 1 489 | 1 426 | 1 315 | 1 569 |
| Staff expenses | — | — | −1 081 | −910 | −1 138 |
| EBITDA | −49 | 44 | −114 | 13 | 132 |
| Depreciation & amort. | −2 | −6 | −6 | −6 | −6 |
| EBIT | −51 | 38 | −120 | 8 | 126 |
| Net financials | −5 | −5 | −5 | −7 | −4 |
| Profit before tax | −31 | 22 | −120 | 5 | 112 |
| Tax | −0 | −0 | — | — | — |
| Net profit | −31 | 22 | −120 | 5 | 112 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 264 | 331 | 183 | 168 | 304 |
| Equity | 124 | 146 | 4 | 9 | 121 |
| Long-term debt | 0 | 0 | 35 | 0 | — |
| Short-term debt | 140 | 175 | 140 | 159 | 173 |
| Total debt | 140 | 175 | 175 | 159 | 173 |
EBITDA margin
8.4%
This company
15.8%
Market median
-47% vs market
20202024
Equity ratio
39.9%
This company
38.2%
Market median
+4% vs market
20202024
Return on equity
92.6%
This company
18.4%
Market median
+403% vs market
20202024
Net profit margin
7.2%
This company
8.1%
Market median
-11% vs market
20202024
Asset turnover
5.16×
This company
1.12×
Market median
+361% vs market
20202024
Debt / equity
1.51×
This company
0.62×
Market median
-144% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2022 | |
| Board of Directors | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Clema Aktiebolag also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Eva-Maria Pernilla Javerud | Deputy Board Member | 0 companies |
| Claes Ivan Javerud | Board of Directors | 0 companies |